| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/09/2002 | EP1169053A1 Pulmonary administration of dry powder formulations for treating infertility |
| 01/09/2002 | EP1169046A1 Pulmonary delivery of protonated/acidified nucleic acids |
| 01/09/2002 | EP1168924A1 In vitro induction of antigen-specific t-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens |
| 01/09/2002 | EP1168923A1 Dna vaccination for treatment of autoimmune disease |
| 01/09/2002 | EP1168919A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion |
| 01/09/2002 | EP1168918A1 Vaccines and gene therapy compositions and methods of making and using the same |
| 01/09/2002 | EP1168917A2 Human lung cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1129210A4 Process for processing sucrose into glucose |
| 01/09/2002 | EP1105516A4 Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation |
| 01/09/2002 | EP1025113A4 Improved process for performing polynucleotide separations |
| 01/09/2002 | EP1023459A4 Determination of cyclin-dependent kinase inhibitor p27 levels as a prognostic factor in cancer patients |
| 01/09/2002 | EP1017841A4 Chromatographic method for mutation detection using mutation site specifically acting enzymes |
| 01/09/2002 | EP1012237A4 Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase |
| 01/09/2002 | EP1009812A4 Transgenic plants with tocopherol methyltransferase |
| 01/09/2002 | EP0959907A4 The butyrophilin gene promoter and uses thereof |
| 01/09/2002 | EP0929663A4 Method of increasing growth and yield in plants |
| 01/09/2002 | EP0873354A4 Novel amp activated protein kinase |
| 01/09/2002 | EP0789764B1 A novel family of protease inhibitors, and other biologic active substances |
| 01/09/2002 | EP0728146B1 Conotoxin peptides |
| 01/09/2002 | EP0716714B1 Oligonucleotides and methods for the detection of Chlamydia trachomatis |
| 01/09/2002 | EP0714444B1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 01/09/2002 | EP0553280B1 Methods for treating cotton-containing fabrics with cellulase |
| 01/09/2002 | EP0495811B1 Production of genetically-engineered vaccines for aids and other retroviral diseases |
| 01/09/2002 | CN1330720A Thioredoxin and grain processing |
| 01/09/2002 | CN1330719A Means and methods for influencing flowering behavious of plants |
| 01/09/2002 | CN1330718A Therapeutically active proteins in plants |
| 01/09/2002 | CN1330717A Transformation system in field of flamentrous fungel hosts in chrysosporium |
| 01/09/2002 | CN1330716A Method for control gene expression in bacterial, namely i(rhizobiaceae) to improved root nodule development, nitrogen fixation and plant blomass production |
| 01/09/2002 | CN1330715A Selectively replicating viral vectors |
| 01/09/2002 | CN1330714A Virulence genes and proteins and their use |
| 01/09/2002 | CN1330713A Zinc finger binding domains for GNN |
| 01/09/2002 | CN1330665A Multiple domain glycoprotein hormones and methods of using |
| 01/09/2002 | CN1330664A Platelet-derived growth factor C, DNA coding therefor and uses thereof |
| 01/09/2002 | CN1330663A Hypoxia-inducible factor I-alpha HIF-I-alpha variants and methods for identifying HIF-I-alpha modulators |
| 01/09/2002 | CN1330662A Heliobacter pylori antigen |
| 01/09/2002 | CN1330661A Procollagen C-proteinase inhibitors |
| 01/09/2002 | CN1330621A Method of vitamin production |
| 01/09/2002 | CN1330555A Antibodies to truncated VEGF-D and uses thereof |
| 01/09/2002 | CN1330511A Herbicid resistant rice |
| 01/09/2002 | CN1330148A Newcastle disease virus HN and chick anemia virus VP3 gene joined antineoplastic biologic preparation |
| 01/09/2002 | CN1330147A Polypeptide-human alpha 2,3-sialyltransferase (ST3 GalVI) 9.57 and polynucleotide for coding it |
| 01/09/2002 | CN1330146A Polypeptide-human dynein receptor-similar kinase 43 and polynucleotide for coding it |
| 01/09/2002 | CN1330145A Polypeptide-NADH dehydrogenase 51kd subunit 10 and polynucleotide for coding it |
| 01/09/2002 | CN1330081A Single-chain antibody resisting HIV-1 outer membrane protein and recombinant immunotoxin |
| 01/09/2002 | CN1330080A Polypeptide-human protein 10 containing P structure domain and polynucleotide for encoding it |
| 01/09/2002 | CN1330079A Polypeptide-RNA polymerase II associated protein 9.57 and polynucleotide for encoding it |
| 01/09/2002 | CN1330078A Polypeptide-negative regulatory factor 9.02 of protein activating GTP enzyme and polynucleotide for coding it |
| 01/09/2002 | CN1329921A Orally applied medicine containing Nostoc which expressing human tumor necrosin factor alpha |
| 01/09/2002 | CN1077598C Method for preparing variant of lipolytic enzyme |
| 01/09/2002 | CN1077438C Recombinant coccidiosis vaccines |
| 01/08/2002 | US6337432 A teratocyte secretory protein nucleic acid molecule; to induce larval development arrest and inhibit crop damage |
| 01/08/2002 | US6337431 Transgenic plants expressing DNA constructs containing a plurality of genes to impart virus resistance |
| 01/08/2002 | US6337430 A gene for creating genetically engineered chimeric plants |
| 01/08/2002 | US6337393 Reducing liquid evaporation during solid phase micro-scale synthesis on an open environment solid support surface; the liquid reagent is a solvent with a high boiling point to prevent evaporation while maintaining a high reaction yield |
| 01/08/2002 | US6337391 Polycation-sensing receptor in aquatic species and methods of use |
| 01/08/2002 | US6337388 Aspergillus fumigatus auxotrophs, auxotrophic markers and polynucleotides encoding same |
| 01/08/2002 | US6337387 A polypeptide encoding a human notch ligand molecule; for suppressing differentiation of undifferentiated cells and drug development |
| 01/08/2002 | US6337317 Amino acid sequence peptides as microbiocides |
| 01/08/2002 | US6337209 Molecular constructs containing a carcinoembryonic antigen regulatory sequence |
| 01/08/2002 | US6337208 A escherichia vector containing a nucleic acid encoding a polypeptide derived from anabaena flos-aquae; the nucleic acid is linked to regulatable expression control sequence; for genetic engineering research |
| 01/08/2002 | US6337207 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 01/08/2002 | US6337206 Nucleic acid encoding mouse galanin receptor (GALR2) |
| 01/08/2002 | US6337201 β-fructofuranosidase and its gene, method of isolating β-fructofuranosidase gene, system for producing β-fructofuranosidase, and β-fructofuranosidase variant |
| 01/08/2002 | US6337199 An isolated protein from erwinia cypripedii; for vitamin c production |
| 01/08/2002 | US6337194 Method for the preparation of insulin by cleavage of a fusion protein and fusion proteins containing insulin A and B chains |
| 01/08/2002 | US6337188 Sequencing a template without prior knowledge of the sequence in conjunction with primer extension in the presence of a labeled chain terminating nucleotide using a reagent having a capture moeity, a spacer region and hybridizing region |
| 01/08/2002 | US6337187 An isolated nucleic acid molecule; diagnosis and therapy for obesity, hypertriglyceridemia, and atherosclerosis |
| 01/08/2002 | US6337186 Method for producing polynucleotides with desired properties |
| 01/08/2002 | US6337185 Method of sequencing |
| 01/08/2002 | US6337183 Screen for compounds with affinity for nucleic acids |
| 01/08/2002 | US6337182 Method for the quantitative determination of DNA sequences |
| 01/08/2002 | US6337100 For coating fat, margarine, soap and shortening |
| 01/08/2002 | US6337074 Antiviral agent capable of disrupting the association of two viral proteins required for dna replication in herpesviruses |
| 01/08/2002 | CA2286287C Hybridisation assay in which excess probe is destroyed |
| 01/08/2002 | CA2246222C Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 01/08/2002 | CA2166198C Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 01/08/2002 | CA2165821C Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
| 01/08/2002 | CA2118113C Oil-body proteins as carriers of high-value peptides in plants |
| 01/08/2002 | CA2116560C Morphogenic protein screening method |
| 01/08/2002 | CA2019559C Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof |
| 01/03/2002 | WO2002001477A1 Method for processing gene expression data, and processing programs |
| 01/03/2002 | WO2002001412A1 Microbe analyzing system and method, and database |
| 01/03/2002 | WO2002000991A1 Method for improving transfection efficiency |
| 01/03/2002 | WO2002000940A2 Image analysis for phenotyping sets of mutant cells |
| 01/03/2002 | WO2002000938A2 Methods and compositions for transcription-based nucleic acid amplification |
| 01/03/2002 | WO2002000936A1 Method for automated molecular cloning |
| 01/03/2002 | WO2002000934A2 Multiply-primed amplification of nucleic acid sequences |
| 01/03/2002 | WO2002000932A2 Diagnosis of known genetic parameters within the mhc |
| 01/03/2002 | WO2002000928A2 Diagnosis of diseases associated with the immune system by determining cytosine methylation |
| 01/03/2002 | WO2002000927A2 Diagnosis of diseases associated with development by means of assessing their methylation status |
| 01/03/2002 | WO2002000926A2 Diagnosis of diseases associated with signal transduction |
| 01/03/2002 | WO2002000924A2 Viral phospholipase a2 enzymes, anti-viral agents and methods of use |
| 01/03/2002 | WO2002000919A2 Screen for identifying inhibitors of glycosylphosphatidylnositol anchoring |
| 01/03/2002 | WO2002000916A2 Methods for identifying an essential gene in a prokaryotic microorganism |
| 01/03/2002 | WO2002000914A2 Bioengineered vehicles for targeted nucleic acid delivery |
| 01/03/2002 | WO2002000913A2 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2 |
| 01/03/2002 | WO2002000907A1 Method for stable chromosomal multi-copy integration of genes |
| 01/03/2002 | WO2002000906A2 Replication deficient adenoviral tnf vector |
| 01/03/2002 | WO2002000905A2 Plant regulatory sequences for selective control of gene expression |
| 01/03/2002 | WO2002000904A2 Recombinant constructs and their use in reducing gene expression |